 cisplatin ifosfamid salvag therapi refractori germ cell carcinoma thirti patient metastat progress germ cell carcinoma first-lin cisplatin chemotherapi salvag regimen consist cisplatin pei IV day week patient tumor-fre end therapi complet respons CR chemotherapi patient addit surgeri patient necros matur teratoma carcinoma patient normal tumor marker unresect residu diseas rm- patient patient CR carcinoma matur teratoma median durat CR month median surviv whole group day rang patient aliv sign progress tumor respons cisplatin therapi respons surviv pei salvag therapi patient prior CR second CR prior unfavor respons median surviv patient prior favor respons day day patient prior unfavor respons myelosuppress dose-limit leukopenia grade thrombocytopenia grade cycl three-drug regimen second CR third patient relaps refractori germ cell carcinoma patient prior favor respons salvag regimen patient prior unfavor respons altern salvag approach